Literature DB >> 26829624

The role of HIV integration in viral persistence: no more whistling past the proviral graveyard.

Frank Maldarelli.   

Abstract

A substantial research effort has been directed to identifying strategies to eradicate or control HIV infection without a requirement for combination antiretroviral therapy (cART). A number of obstacles prevent HIV eradication, including low-level viral persistence during cART, long-term persistence of HIV-infected cells, and latent infection of resting CD4+ T cells. Mechanisms of persistence remain uncertain, but integration of the provirus into the host genome represents a central event in replication and pathogenesis of all retroviruses, including HIV. Analysis of HIV proviruses in CD4+ lymphocytes from individuals after prolonged cART revealed that a substantial proportion of the infected cells that persist have undergone clonal expansion and frequently have proviruses integrated in genes associated with regulation of cell growth. These data suggest that integration may influence persistence and clonal expansion of HIV-infected cells after cART is introduced, and these processes may represent key mechanisms for HIV persistence. Determining the diversity of host genes with integrants in HIV-infected cells that persist for prolonged periods may yield useful information regarding pathways by which infected cells persist for prolonged periods. Moreover, many integrants are defective, and new studies are required to characterize the role of clonal expansion in the persistence of replication-competent HIV.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26829624      PMCID: PMC4731194          DOI: 10.1172/JCI80564

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  125 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

Review 2.  HIV reservoirs and the possibility of a cure for HIV infection.

Authors:  S Palmer; L Josefsson; J M Coffin
Journal:  J Intern Med       Date:  2011-10-27       Impact factor: 8.989

3.  BACH2: a marker of DNA damage and ageing.

Authors:  L M Uittenboogaard; C Payan-Gomez; J Pothof; W van Ijcken; P G Mastroberardino; I van der Pluijm; J H J Hoeijmakers; M Tresini
Journal:  DNA Repair (Amst)       Date:  2013-09-24

4.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

5.  Activation and repression of cellular immediate early genes by serum response factor cofactors.

Authors:  Seung-Min Lee; Mansi Vasishtha; Ron Prywes
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

Review 6.  HIV viral dynamics.

Authors:  J M Coffin
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

7.  A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection.

Authors:  Hiroyu Hatano; Rebecca Scherzer; Yuaner Wu; Kara Harvill; Kristinalisa Maka; Rebecca Hoh; Elizabeth Sinclair; Sarah Palmer; Jeffrey N Martin; Michael P Busch; Steven G Deeks; Priscilla Y Hsue
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 9.  Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?

Authors:  Wasim Abbas; Muhammad Tariq; Mazhar Iqbal; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2015-03-31       Impact factor: 5.048

10.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more
  17 in total

1.  Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Authors:  Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 2.  The mutable vaccine for mutable viruses.

Authors:  Marilia Cascalho; Samuel J Balin; Jeffrey L Platt
Journal:  Immunotherapy       Date:  2017-06       Impact factor: 4.196

3.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

4.  Impact of Suboptimal APOBEC3G Neutralization on the Emergence of HIV Drug Resistance in Humanized Mice.

Authors:  Matthew M Hernandez; Audrey Fahrny; Ravi Sachidanandam; Roberto F Speck; Viviana Simon; Anitha Jayaprakash; Gustavo Gers-Huber; Marsha Dillon-White; Annette Audigé; Lubbertus C F Mulder
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 5.  Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses.

Authors:  Noemi Linden; R Brad Jones
Journal:  Trends Immunol       Date:  2022-07-08       Impact factor: 19.709

6.  HIV infection results in clonal expansions containing integrations within pathogenesis-related biological pathways.

Authors:  Kevin G Haworth; Lauren E Schefter; Zachary K Norgaard; Christina Ironside; Jennifer E Adair; Hans-Peter Kiem
Journal:  JCI Insight       Date:  2018-07-12

7.  A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication.

Authors:  Chiara Orlandi; Benedetta Canovari; Federica Bozzano; Francesco Marras; Zeno Pasquini; Francesco Barchiesi; Andrea De Maria; Mauro Magnani; Anna Casabianca
Journal:  J Transl Med       Date:  2020-05-19       Impact factor: 5.531

Review 8.  Insight into treatment of HIV infection from viral dynamics models.

Authors:  Alison L Hill; Daniel I S Rosenbloom; Martin A Nowak; Robert F Siliciano
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

9.  Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice.

Authors:  Nirk E Quispe Calla; Rodolfo D Vicetti Miguel; Melissa E Glick; Jesse J Kwiek; Janelle M Gabriel; Thomas L Cherpes
Journal:  J Int AIDS Soc       Date:  2018-01       Impact factor: 5.396

10.  Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells.

Authors:  Emilie Battivelli; Matthew S Dahabieh; Mohamed Abdel-Mohsen; J Peter Svensson; Israel Tojal Da Silva; Lillian B Cohn; Andrea Gramatica; Steven Deeks; Warner C Greene; Satish K Pillai; Eric Verdin
Journal:  Elife       Date:  2018-05-01       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.